Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Keiji Hanada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3196-8551; OpenAlex author ID A5032999357, A5121063312. Sources: OpenAlex.

Their work

Papers
36 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
121
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 4 papers · 2018: 5 papers · 2019: 2 papers · 2020: 3 papers · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 9 papers

Papers 36

  1. Clinical outcomes and recurrence patterns in pancreatic ductal adenocarcinoma diagnosed at an early stage: insights from a multicenter cohort study in Japan. Co-author DOI 10.1007/s00535-025-02340-x↗
  2. Establishment of simple pancreatic ductal adenocarcinoma identification method: S100P measurement in duodenal fluid obtained during upper gastrointestinal endo… First author DOI 10.1016/j.pan.2025.12.020↗
  3. A community-hospital collaborative diagnostic pathway for earlier detection of pancreatic cancer: Long-term impact of the Onomichi Method. Co-author DOI 10.1016/j.pan.2026.04.011↗
  4. Identifying risk factors for pancreatic cancer in a large Japanese cohort using an insurance and health check-up database. First author DOI 10.1016/j.pan.2026.04.012↗
  5. Clinical Practice Guidelines for Pancreatic Cancer 2025 From the Japan Pancreas Society: A Synopsis. Co-author DOI 10.1097/mpa.0000000000002600↗
  6. Comparative Study of Pathological and Imaging Findings in High-Grade Pancreatic Intraepithelial Neoplasia: A Multicenter Analysis by the Japan Study Group on E… Co-author DOI 10.1097/mpa.0000000000002710↗
  7. KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006645↗
  8. Current Role of Endoscopic Ultrasonography in the Early Detection of Pancreatic Cancer: Recognition of Indirect Imaging Findings and Diagnostic Strategy. Co-author DOI 10.2169/internalmedicine.8054-26↗
  9. Early detection of pancreatic ductal adenocarcinoma by single-molecule profiling of pancreatic enzyme activities Co-author DOI 10.64898/2026.06.05.730533↗
  10. Potential of Carbohydrate Antigen 19-9 and Serum Apolipoprotein A2-Isoforms in the Diagnosis of Stage 0 and IA Pancreatic Cancer. Co-author DOI 10.3390/diagnostics14171920↗
  11. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Co-author DOI 10.1007/s10147-023-02317-x↗
  12. Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: … Co-author DOI 10.3390/diagnostics13162696↗
  13. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer. Co-author DOI 10.1016/j.ejso.2020.09.008↗
  14. Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study. Co-author DOI 10.3390/diagnostics11020287↗
  15. Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis. Co-author DOI 10.1097/mpa.0000000000001513↗
  16. Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study. Co-author DOI 10.1097/mpa.0000000000001579↗
  17. Endoscopic Ultrasonography Diagnosis of Early Pancreatic Cancer. First author DOI 10.3390/diagnostics10121086↗
  18. Advances in Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010018↗
  19. Roles of ERCP in the Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010030↗
  20. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2018.04.022↗
  21. Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan. Co-author DOI 10.1016/j.gie.2018.01.021↗
  22. Multicenter study of early pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2017.11.007↗
  23. Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of … First author DOI 10.1097/mpa.0000000000001021↗
  24. [Social programs for early diagnosis of pancreatic cancer -establishment of network between special doctors and practicing doctors]. Co-author DOI 10.11405/nisshoshi.115.327↗
  25. Early diagnosis of pancreatic cancer: Current trends and concerns. Co-author DOI 10.1002/ags3.12004↗
  26. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis. Co-author DOI 10.1097/mpa.0000000000000816↗
  27. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.21873/anticanres.12031↗
  28. Familial pancreatic cancer: Concept, management and issues. Co-author DOI 10.3748/wjg.v23.i6.935↗
  29. Diagnostic strategies for early pancreatic cancer. Co-author DOI 10.1007/s00535-014-1026-z↗
  30. Effective screening for early diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.bpg.2015.09.017↗
  31. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis. Co-author DOI 10.1093/jjco/hyu127↗
  32. [Recent advances in the early diagnosis of pancreatic cancer]. Co-author PMID 24305092↗
  33. Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinic… Co-author DOI 10.1007/s00280-012-1822-1↗
  34. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of … First author DOI 10.1097/mpa.0b013e31823c0b05↗
  35. [Discussion meeting on is it possible to detect pancreatic cancer in early stage?]. Co-author DOI 10.2169/naika.101.120↗
  36. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Co-author DOI 10.1097/mpa.0b013e318215010c↗

Closest collaborators

The 25 strongest of 121 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayuki Kitano · 9 shared papers, 2017–2026 · strength 1.35
  2. Akinori Shimizu · 6 shared papers, 2018–2026 · strength 0.95
  3. Tomoyuki Minami · 8 shared papers, 2015–2026 · strength 0.93
  4. Yasutaka Ishii · 5 shared papers, 2021–2026 · strength 0.93
  5. Juri Ikemoto · 7 shared papers, 2015–2026 · strength 0.89
  6. Takao Ohtsuka · 4 shared papers, 2018–2026 · strength 0.79
  7. Mamoru Takenaka · 4 shared papers, 2018–2026 · strength 0.60
  8. Atsushi Masamune · 4 shared papers, 2018–2026 · strength 0.53
  9. Chigusa Morizane · 3 shared papers, 2017–2026 · strength 0.51
  10. Tomoyuki Abe · 5 shared papers, 2017–2021 · strength 0.50
  11. Masanobu Yukutake · 3 shared papers, 2021–2026 · strength 0.49
  12. Atsushi Yamaguchi · 3 shared papers, 2021–2026 · strength 0.49
  13. Reiko Ashida · 3 shared papers, 2017–2026 · strength 0.47
  14. Noboru Ideno · 2 shared papers, 2026 · strength 0.46
  15. Kazuo Hara · 2 shared papers, 2026 · strength 0.44
  16. Atsushi Kanno · 4 shared papers, 2014–2026 · strength 0.44
  17. Nobutaka Sasaki · 1 shared paper, 2026 · strength 0.43
  18. Shinya Nakamura · 2 shared papers, 2023–2026 · strength 0.39
  19. Akio Yanagisawa · 3 shared papers, 2018–2026 · strength 0.38
  20. Toru Furukawa · 4 shared papers, 2011–2026 · strength 0.36
  21. Nobumasa Mizuno · 3 shared papers, 2014–2026 · strength 0.34
  22. Shuji Yonehara · 5 shared papers, 2012–2019 · strength 0.33
  23. Masafumi Nakamura · 2 shared papers, 2018–2026 · strength 0.33
  24. Michimoto Kobayashi · 1 shared paper, 2024 · strength 0.31
  25. Toshio Noriyuki · 3 shared papers, 2017–2021 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.